AstraZeneca Sues Mylan Over Planned Vimovo Generic
AstraZeneca AB and Pozen Inc. on Friday sued Mylan Pharmaceuticals Inc. in New Jersey federal court, alleging the generic-drug maker had infringed on seven patents with its planned generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article